Market Movers (8-K)
See all →OQB
Verde Resources, Inc. announces a significant 10-year Master Commercialization and Collaboration Agreement with Ergon Asphalt & Emulsions, Inc. to integrate engineered biochar into road paving products and generate carbon credits.
OQB
Verde Resources has established a new wholly owned subsidiary in Singapore to serve as its Asia Pacific headquarters and facilitate global technology licensing.
OQB
Verde Resources' subsidiary, Verde Renewables, enters an exclusive 18-month supply agreement with Biochar Solutions LLC for engineered biochar, targeting asphalt applications and carbon credit generation.
OQB
Verde Resources, Inc. stockholders approved all eleven proposals at the 2026 Annual Meeting, including director elections, auditor ratification, executive compensation, and significant corporate governance amendments.
Capital raise
OQB
Verde Resources, Inc. announced details for its 2026 Annual Meeting of Stockholders, including the virtual meeting date and deadlines for shareholder proposals and director nominations.
Delay expected
OQB
Verde Resources Inc. announced a $2 million strategic investment from commercial partner Ergon Asphalt & Emulsions, strengthening its balance sheet and advancing its BioAsphalt technology.
Capital raise
Better than expected
Quarterly Earnings (10-Q)
See all →OQB
Verde Resources, Inc. announced its third quarter fiscal year 2026 financial results, highlighting a significant increase in revenue driven by initial sales of its Verde V24 product.
Capital raise
OQB
Verde Resources, a sustainable road construction materials company, reported a reduced net loss for Q2 2025 despite a significant revenue drop, driven by strategic shifts and new commercial partnerships.
Capital raise
OQB
Verde Resources reported a significant net loss in Q1 2026, driven by a strategic shift to an upgraded BioAsphalt formulation and reduced sales, despite key commercialization milestones and a new licensing deal with Ergon.
Worse than expected
Capital raise
Delay expected
OQB
Verde Resources' Q3 2025 filing details financial results and highlights advancements in its Biochar-Asphalt technology, including successful demonstrations and carbon credit generation.
Worse than expected
Capital raise
OQB
Verde Resources' Q2 2025 report details financial results and highlights advancements in its Biochar-Asphalt technology, including successful demonstrations and strategic partnerships.
Worse than expected
Capital raise
OQB
Verde Resources, Inc. released its Q1 2025 financial results, showcasing a strategic shift towards green technology and sustainable infrastructure solutions.
Better than expected
Capital raise
Annual Reports (10-K)
OQB
Verde Resources, Inc. expands its sustainable infrastructure technology with an exclusive licensing agreement with Ergon for North America, despite reporting a net loss of $4.78 million for fiscal year 2025.
Capital raise
Worse than expected
OQB
Verde Resources Inc. has transitioned from mining and CBD to focus on renewable energy and sustainable development, highlighted by a partnership with the National Center for Asphalt Technology (NCAT) to test its biochar-asphalt technology.
Worse than expected
Capital raise
OQB
Verde Resources Inc. files an amended 10-K, highlighting its strategic shift from mining to renewable energy and sustainable development, including biochar-asphalt projects and carbon credit generation.
Worse than expected
Capital raise
Proxy Statements (Def-14A)
OQB
Verde Resources, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on February 25, 2026, where shareholders will vote on director elections, executive compensation, and significant corporate governance amendments.
Capital raise
New Public Companies (S-1)
OQB
Verde Resources, Inc. announces an addendum to its Joint Development Agreement, expanding licensed territories to the US, Mexico, and Canada, and solidifying its strategic relationship with Ergon.
Capital raise
OQB
Verde Resources, a sustainable road construction materials company, files an S-1 registration statement for a public offering and Nasdaq listing, highlighting its BioAsphalt technology and exclusive licensing agreement with Ergon.
Delay expected
Capital raise
Worse than expected